EPO and telangiectasis: First described in 2011, the TEMPI acronym denotes (1) telangiectasias, (2) elevated erythropoietin and erythrocytosis, (3) monoclonal gammopathy, (4) perinephric fluid collections, and (5) intrapulmonary shunting, that are the hallmark of this very rare paraneoplastic syndrome [2, 3].